Light chain deposition disease in an older adult patient successfully treated with long-term administration of bortezomib, melphalan and prednisone

Hiroto Hiyamuta, Shunsuke Yamada, Yuta Matsukuma, Akihiro Tsuchimoto, Toshiaki Nakano, Masatomo Taniguchi, Kosuke Masutani, Goichi Yoshimoto, Tsuyoshi Muta, Koichi Akashi, Takanari Kitazono, Kazuhiko Tsuruya

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A 70-year-old woman was admitted to our hospital because of fatigue and renal dysfunction and was diagnosed with light chain deposition disease (LCDD) with multiple organ involvement (kidney, thyroid gland, heart and eyes). After chemotherapy with bortezomib, cyclophosphamide and dexamethasone, hepatobiliary enzyme levels increased abruptly. A liver biopsy showed light chain deposition in Disse spaces. After two years of treatment with bortezomib, melphalan and prednisone (VMP) administered at shorter intervals relative to regular cycles, the patient showed a hematological and organ response. This case indicates that a relatively low dose intensity VMP regimen is preferable for elderly patients with LCDD with multiple organ involvement.

Original languageEnglish (US)
Pages (from-to)1319-1325
Number of pages7
JournalInternal Medicine
Volume55
Issue number10
DOIs
StatePublished - 2016

Fingerprint

Melphalan
Prednisone
Light
Kidney
Cyclophosphamide
Dexamethasone
Fatigue
Thyroid Gland
Biopsy
Drug Therapy
Liver
Enzymes
Bortezomib
Therapeutics

Keywords

  • Cardiac involvement
  • Liver involvement
  • Multiple myeloma
  • Ocular involvement
  • VMP therapy

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Light chain deposition disease in an older adult patient successfully treated with long-term administration of bortezomib, melphalan and prednisone. / Hiyamuta, Hiroto; Yamada, Shunsuke; Matsukuma, Yuta; Tsuchimoto, Akihiro; Nakano, Toshiaki; Taniguchi, Masatomo; Masutani, Kosuke; Yoshimoto, Goichi; Muta, Tsuyoshi; Akashi, Koichi; Kitazono, Takanari; Tsuruya, Kazuhiko.

In: Internal Medicine, Vol. 55, No. 10, 2016, p. 1319-1325.

Research output: Contribution to journalArticle

Hiyamuta, H, Yamada, S, Matsukuma, Y, Tsuchimoto, A, Nakano, T, Taniguchi, M, Masutani, K, Yoshimoto, G, Muta, T, Akashi, K, Kitazono, T & Tsuruya, K 2016, 'Light chain deposition disease in an older adult patient successfully treated with long-term administration of bortezomib, melphalan and prednisone', Internal Medicine, vol. 55, no. 10, pp. 1319-1325. https://doi.org/10.2169/internalmedicine.55.5752
Hiyamuta, Hiroto ; Yamada, Shunsuke ; Matsukuma, Yuta ; Tsuchimoto, Akihiro ; Nakano, Toshiaki ; Taniguchi, Masatomo ; Masutani, Kosuke ; Yoshimoto, Goichi ; Muta, Tsuyoshi ; Akashi, Koichi ; Kitazono, Takanari ; Tsuruya, Kazuhiko. / Light chain deposition disease in an older adult patient successfully treated with long-term administration of bortezomib, melphalan and prednisone. In: Internal Medicine. 2016 ; Vol. 55, No. 10. pp. 1319-1325.
@article{f0f6760789624bcb9fcee2ff6508d4db,
title = "Light chain deposition disease in an older adult patient successfully treated with long-term administration of bortezomib, melphalan and prednisone",
abstract = "A 70-year-old woman was admitted to our hospital because of fatigue and renal dysfunction and was diagnosed with light chain deposition disease (LCDD) with multiple organ involvement (kidney, thyroid gland, heart and eyes). After chemotherapy with bortezomib, cyclophosphamide and dexamethasone, hepatobiliary enzyme levels increased abruptly. A liver biopsy showed light chain deposition in Disse spaces. After two years of treatment with bortezomib, melphalan and prednisone (VMP) administered at shorter intervals relative to regular cycles, the patient showed a hematological and organ response. This case indicates that a relatively low dose intensity VMP regimen is preferable for elderly patients with LCDD with multiple organ involvement.",
keywords = "Cardiac involvement, Liver involvement, Multiple myeloma, Ocular involvement, VMP therapy",
author = "Hiroto Hiyamuta and Shunsuke Yamada and Yuta Matsukuma and Akihiro Tsuchimoto and Toshiaki Nakano and Masatomo Taniguchi and Kosuke Masutani and Goichi Yoshimoto and Tsuyoshi Muta and Koichi Akashi and Takanari Kitazono and Kazuhiko Tsuruya",
year = "2016",
doi = "10.2169/internalmedicine.55.5752",
language = "English (US)",
volume = "55",
pages = "1319--1325",
journal = "Internal Medicine",
issn = "0918-2918",
publisher = "Japanese Society of Internal Medicine",
number = "10",

}

TY - JOUR

T1 - Light chain deposition disease in an older adult patient successfully treated with long-term administration of bortezomib, melphalan and prednisone

AU - Hiyamuta, Hiroto

AU - Yamada, Shunsuke

AU - Matsukuma, Yuta

AU - Tsuchimoto, Akihiro

AU - Nakano, Toshiaki

AU - Taniguchi, Masatomo

AU - Masutani, Kosuke

AU - Yoshimoto, Goichi

AU - Muta, Tsuyoshi

AU - Akashi, Koichi

AU - Kitazono, Takanari

AU - Tsuruya, Kazuhiko

PY - 2016

Y1 - 2016

N2 - A 70-year-old woman was admitted to our hospital because of fatigue and renal dysfunction and was diagnosed with light chain deposition disease (LCDD) with multiple organ involvement (kidney, thyroid gland, heart and eyes). After chemotherapy with bortezomib, cyclophosphamide and dexamethasone, hepatobiliary enzyme levels increased abruptly. A liver biopsy showed light chain deposition in Disse spaces. After two years of treatment with bortezomib, melphalan and prednisone (VMP) administered at shorter intervals relative to regular cycles, the patient showed a hematological and organ response. This case indicates that a relatively low dose intensity VMP regimen is preferable for elderly patients with LCDD with multiple organ involvement.

AB - A 70-year-old woman was admitted to our hospital because of fatigue and renal dysfunction and was diagnosed with light chain deposition disease (LCDD) with multiple organ involvement (kidney, thyroid gland, heart and eyes). After chemotherapy with bortezomib, cyclophosphamide and dexamethasone, hepatobiliary enzyme levels increased abruptly. A liver biopsy showed light chain deposition in Disse spaces. After two years of treatment with bortezomib, melphalan and prednisone (VMP) administered at shorter intervals relative to regular cycles, the patient showed a hematological and organ response. This case indicates that a relatively low dose intensity VMP regimen is preferable for elderly patients with LCDD with multiple organ involvement.

KW - Cardiac involvement

KW - Liver involvement

KW - Multiple myeloma

KW - Ocular involvement

KW - VMP therapy

UR - http://www.scopus.com/inward/record.url?scp=84968854162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84968854162&partnerID=8YFLogxK

U2 - 10.2169/internalmedicine.55.5752

DO - 10.2169/internalmedicine.55.5752

M3 - Article

C2 - 27181540

AN - SCOPUS:84968854162

VL - 55

SP - 1319

EP - 1325

JO - Internal Medicine

JF - Internal Medicine

SN - 0918-2918

IS - 10

ER -